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Abstract
Background: Intermediate-conductance, calcium-activated potassium channels (IKs) modulate proliferation and
differentiation in mesodermal cells by enhancing calcium influx, and they contribute to the physiology of fluid
movement in certain epithelia. Previous reports suggest that IK channels stimulate proliferative growth in a
keratinocyte cell line; however, because these channels indirectly promote calcium influx, a critically unique
component of the keratinocyte differentiation program, an alternative hypothesis is that they would be anti-
proliferative and pro-differentiating. This study addresses these hypotheses.
Methods: Real-time PCR, patch clamp electrophysiology, and proliferation assays were used to determine if
human IK1 (hIK1) expression and function are correlated with either proliferation or differentiation in cultured
human skin epidermal keratinocytes, and skin biopsies grown in explant culture.
Results: hIK1 mRNA expression in human keratinocytes and skin was increased in response to anti-proliferative/
pro-differentiating stimuli (elevated calcium and Vitamin D). Correspondingly, the hIK1 agonist 1-EBIO inhibited
keratinocyte proliferation suggesting that the channel could be anti-proliferative and pro-differentiating. However,
this proliferative inhibition by 1-EBIO was not reversed by a panel of hIK1 blockers, calling into question the
mechanism of 1-EBIO action. Subsequent patch clamp electrophysiological analysis failed to detect hIK1 channel
currents in keratinocytes, even those expressing substantial hIK1 mRNA in response to calcium and Vitamin D
induced differentiation. Identical electrophysiological recording conditions were then used to observe robust IK1
currents in fibroblasts which express IK1 mRNA levels comparable to those of keratinocytes. Thus, the absence
of observable hIK1 currents in keratinocytes was not a function of the electrophysiological techniques.
Conclusion:  Human keratinocyte differentiation is stimulated by calcium mobilization and influx, and
differentiation stimuli coordinately upregulate mRNA levels of the calcium-activated hIK1 channel. This
upregulation is paradoxical in that functional hIK1 channels are not observed in cultured keratinocytes. It appears,
therefore, that hIK1 does not contribute to the functional electrophysiology of primary human keratinocytes, nor
intact human skin. Further, the results indicate caution is required when interpreting experiments utilizing
pharmacological hIK1 modulators in human keratinocytes.
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Background
Intermediate conductance, calcium-activated potassium
channels (IKs) stimulate proliferative growth in T-cells
and fibroblasts [1,2], via their ability to maintain a nega-
tive membrane potential, thus enhancing the electromo-
tive driving force for calcium entry [3], a mitogenic
requirement in these cells. IKs have also been suggested to
modulate secretion and cell volume in epithelial cells
from the gut and airways [4-7], but it is not known if these
channels also exert a growth control function in either iso-
lated epithelial cells or intact epithelia. Unlike in T-cells
and fibroblasts, stimulated calcium entry in human epi-
dermal keratinocytes is associated with cessation (rather
than enhancement) of proliferation, as well as promotion
of the differentiation program [8]. Therefore, although
across different cell types IKs may be expected to produce
equivalent electrophysiological effects including the
enhancement of calcium entry, in epithelial cells typified
by keratinocytes this action may serve to limit prolifera-
tive activity and promote differentiation, the converse of
IK function in T-cells and fibroblasts.
In support of a growth regulatory role for IK channels in
human epidermal keratinocytes, the immortalized, non-
tumorigenic human keratinocyte cell line HaCaT has been
shown to express human IK1 (hIK1) [9]. Interestingly,
prolonged exposure of HaCaT to the IK activator, 1-EBIO,
was reported to downregulate IK expression, an effect cor-
related with proliferative inhibition [10]. These results,
although complicated by agonist induced channel expres-
sion changes, suggest a pro-proliferative role for IK in
keratinocytes. Further, although potassium conductances
have been reported in studies of primary, non-immortal-
ized keratinocytes, it is unclear if these conductances are
due to IK [11,12]. Thus, the exact physiological role of IK
channels in primary human keratinocytes and in intact
skin remains undetermined.
Methods
Cell Culture
Adult human epidermal keratinocytes (Cascade Biologics,
Inc., Portland, OR or Cambrex Bio Science, Walkersville,
MD) were cultured per the supplier's instructions in EpiL-
ife Medium with Human Keratinocyte Growth Supple-
ment (bovine pituitary extract, 0.2% v/v; bovine insulin,
5 µg/ml; hydrocortisone, 0.18 µg/ml; bovine transferrin, 5
µg/ml and human epidermal growth factor, 0.2 ng/
ml)(Cascade Biologics) in a 5% CO2, 37°C incubator.
Basal calcium concentration was 0.06 mM. Stock cell cul-
tures were passaged so as to maintain density at less than
70%, and cultures were not used for more than six weeks
after direct receipt from the supplier (typically within 5–
10 passages). For gene expression and physiological stud-
ies keratinocytes were plated at densities of approximately
30–40% confluence at the start of the experiment.
Medium was then refreshed with or without various
agents for chronic exposure experiments. Medium and
additions were replenished every other day thereafter for
the duration of the experiment.
Cell proliferation and toxicity assays
Keratinocytes were seeded in a 96-well plate at 10 × 103/
well in standard growth medium. After 2–4 hours (to
allow attachment to substrate) test agents and 1 µCi 3H-
thymidine (Perkin Elmer Life Sciences/NEN Life Sciences,
Boston, MA) were added. Approximately 24 hours later
cells were harvested for scintillation counting of incorpo-
rated thymidine, expressed as CPM (each experimental
group represents mean ± SEM of triplicate samples). The
CytoTox 96 Non-Radioactive Cytotoxicity Assay Kit
(Promega, Madison, WI) was used to measure potential
cytotoxic actions of test compounds.
Electrophysiology
Standard patch clamp techniques were used to attempt to
record hIK1 currents in keratinocytes, and these proce-
dures as applied to IK1 recordings from fibroblast cells
have been extensively described ([13-15], and references
therein). To facilitate patch seal formation and recording
cells were rounded by brief (1–2 min) exposure to
trypsin/EDTA, after which they were switched to the bath
solution (in mM): 138 NaCl, 9 KCl, 1 CaCl2, 1 MgCl2, and
10 HEPES. The patch pipette solution was 150 KCl, 1
MgCl2, 10 HEPES, with free calcium adjusted via addition
of EGTA/calcium as described below. All solutions were at
pH 7.4 and between 320–325 mOsm. Pipette resistances
were between 2–4 MΩ. Cells were held at -70 mV and
stepped to 0 mV (for 100 msec) in the presence of elevated
intracellular calcium in order to activate hIK1 or mIK1
channels. Two approaches were used to elevate intracellu-
lar calcium to activate calcium-dependent currents. Either
the free calcium concentration of the patch pipette solu-
tion was set to 10 µM (1 mM EGTA with 10 mM calcium),
or the pipette solution contained only 0.1 mM EGTA (see
above) and intracellular calcium was increased by extra-
cellularly applying 10 µM calcium ionophore (A23187)
for 1–2 minutes. Compounds including A23187 were
acutely applied to patch clamped cells by dissolving them
in the bath solution, and then pressure ejecting the solu-
tion from blunt-tipped micropipettes positioned about 5–
10 µM from the cell. All recordings were performed at
ambient temperatures (21–23°C).
Skin biopsies
Skin biopsies (5 mm punches) were obtained from
healthy donors via the Cooperative Human Tissue Net-
work, Midwestern Division (Columbus, OH). For imme-
diate RNA isolation biopsies were placed into RNALater
(Ambion, Austin, TX) at the time of donation and shipped
overnight in this solution. For experiments on living tis-BMC Dermatology 2004, 4 http://www.biomedcentral.com/1471-5945/4/7
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sue biopsies were placed into EpiLife alone (with 1.4 mM
calcium) and shipped overnight on ice. Upon arrival in
the lab living biopsies were trimmed of extraneous sub-
dermal and dermal tissue, and were cultured in 6-well cul-
ture plates in EpiLife (with 1.4 mM calcium) in a 5% CO2,
37°C incubator. Medium with or without test agents was
refreshed daily. All skin biopsies were obtained under pro-
cedures approved by the Institutional Review Board of the
Evanston Northwestern Healthcare Research Institute.
RNA Isolation
Total RNA was extracted from cultured human keratinoc-
ytes and skin biopsies with the RNAqueous phenol-free
RNA isolation kit (Ambion, Austin, TX). RNAlater
(Ambion) preserved skin samples were homogenized in
RNAqueous lysis buffer with an IKA Works Ultra-Turrax
T8 dispersing instrument (IKA Works, Wilmington, NC).
Cell debris were removed from the homogenates by cen-
trifuging for two to three minutes at 12,000 g. RNA was
subsequently purified according to manufacturer's
instructions. Keratinocytes were washed twice with Dul-
becco's Phosphate Buffered Saline then homogenized
with lysis buffer directly in culture dishes using a cell
scraper. Keratinocyte RNA was purified as per instructions
of manufacturer. RNA concentrations were determined by
measuring absorbance at 260 nm. Ratios of absorbance at
260/280 nm yielded values between 1.8 and 2.1. All sam-
ples were DNase treated for at least 1 hr prior to reverse
transcription.
RT-PCR
cDNA was synthesized by reverse transcribing 0.5–2 µg of
total RNA using Power Script reverse transcriptase (BD
Biosciences Clontech, Palo Alto, CA) in a 40 µL reaction.
Briefly, samples were pre-incubated at 70°C with 20 ng of
random decamers (Ambion) for two minutes, cooled on
ice then incubated at 42°C for 90 minutes. Reactions were
terminated with a final 15°C incubation for 15 minutes.
Expression levels of the targeted mRNA were quantified
by fluorescent real-time polymerase chain reaction using
an ABI Prism 7700 Sequence Detector (Applied Biosys-
tems, Foster City, CA). Real-time PCR reactions were per-
formed in triplicate in a total volume of 30 µL containing
1  µL of cDNA, 15 µL of Universal PCR Master Mix
(Applied Biosystems), 300–900 nM of each forward and
reverse primer and 200 nM of each probe. Gene specific
Taq-Man primers and probes were designed and synthe-
sized using the Primer Express software package (Applied
Biosystems). Primer and probe sequences for hIK1 were
(5'-3'): GTGAACTCCATGGTGGACATCTC (forward),
CGGTGTGAGCTGCTCAGATTC (reverse), ATGCACAT-
GATCCTGTATGACCTGCAGC (probe); and, for mIK1:
TGCCTTCCTCCTTTGTCTTATTGT (forward),
AGCCCGTTGTCAGTCATGAAC (reverse), TCTTCCAT-
GCCAAGGAGGTCCAGC (probe). Probes were labeled
with the fluorescence reporter FAM at the 5' end, and the
fluorescence quencher TAMRA at the 3' end. GAPDH was
detected using primers and a VIC labeled probe purchased
from Applied Biosystems as a Pre-developed Taq-Man
Assay Reagent. PCR reaction conditions were as follows:
two minutes at 50°C to activate uracil-N-glycosylase
(Amp-Erase UNG) 95°C for 5 minutes to deactivate UNG,
40 cycles at 95°C for 15 seconds and 60°C for one
minute. The relative quantification of mRNA, described as
either fold change from control or % of GAPDH, was
determined by the comparative Ct method where the tar-
get is normalized to the endogenous reference GAPDH.
The threshold Ct value is the cycle number arbitrarily
selected from the logarithmic phase of the PCR curve
where an increase in fluorescence can be detected above
background. The ∆Ct is determined by subtracting the Ct
of GAPDH from the Ct of the target (∆Ct = Ct-target – Ct-
GAPDH). The relative value of target to endogenous refer-
ence is described as % of GAPDH = 2-∆Ct. Fold change
from control = 2-∆∆Ct where ∆∆Ct = ∆Ct-control – ∆Ct-
treatment.
To perform end-point PCR for 1281 bp of the 1284 bp
coding sequence of hIK1 PCR reactions were run in a reac-
tion volume of 50 µL using Advantage-GC 2 Polymerase
with 15 µL of GC melt (BD Biosciences Clontech, Palo
Alto, CA), 1X GC 2 PCR Buffer, 200 µM dNTP, 0.4 µM of
each primer and 5 µL of cDNA. PCR reaction parameters
were as follows: 94°C for 3 minutes, 35 cycles of 94°C for
15 seconds and 68°C 3 minutes, and a final extension at
68°C for 3 minutes. PCR for the amplification of GAPDH
mRNA was performed in the same manner except 30
cycles were used and the GC melt was omitted. Primer
sequences for hIK1 were (5'-3'): ATGGGCGGGGATCT-
GGTGCTT (forward), CTTGGACTGCTGGCTGGGTTC
(reverse). GAPDH primers (Maxim Biotech, Inc., San
Francisco, CA) were (5'-3'): TGCTGGCGCTGAG-
TACGTCGT (forward), GTGGAGGAGTGGGTGTCGCTG
(reverse) yielding a PCR product of 615 bp. PCR products
were analyzed on a 1.5% agarose gel stained with ethid-
ium bromide.
Reagents and chemicals
The following compounds were prepared as stocks for
application to cell cultures or single cells after appropriate
dilution in either culture medium or physiological saline,
respectively. VitD (calcitriol; 1,25-(OH)2-D3, Sigma
Corp., St. Louis, MO) in DMSO; A23187 in DMSO
(Sigma); 50 mM 1-EBIO (1-ethyl-2-benzimidazolinone,
Tocris Cookson Inc., Ellisville, MO) in ethanol; 25 mM
clotrimazole (Sigma) in ethanol; 10 µM charybdotoxin
( T o c r i s )  i n  1 0  m M  a c e t i c  a c i d  w i t h  0 . 1 %  B S A ;  1  m M
TRAM-34 in DMSO. TRAM-34 was a generous gift of Dr.
Heike Wulff (UC Davis School of Medicine). Correspond-BMC Dermatology 2004, 4 http://www.biomedcentral.com/1471-5945/4/7
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ing vehicle controls showed no effect on cell proliferation,
cell toxicity, electrophysiology, or gene expression.
Data Analysis
Numerical results are given as mean ± SEM unless other-
wise noted. One-way ANOVA was used for comparisons
of treated groups to a control no-treatment group, as well
as for pairwise comparisons among treatment groups. The
95% confidence interval was used to assess significance
for these analyses.
Results and Discussion
hIK1 mRNA expression in proliferating and differentiating 
human keratinocytes
We examined whether or not hIK1 mRNA is expressed in
primary human epidermal keratinocytes, and if this
expression is altered by addition of VitD at 1 µM, a con-
centration which is maximal for anti-proliferative/pro-dif-
ferentiating effects [16], or elevation of extracellular
calcium from 0.06 to 2.0 mM. Both of these perturbations
induce expression of differentiation genes, with elevated
calcium also producing profound morphological changes
consistent with the onset of the differentiation program
[17,18]. Both elevated calcium and VitD significantly
increased hIK1 mRNA levels within 24 hours and these
increases were maintained over the course of five days
exposure (figure 1). The combination of VitD and ele-
vated calcium produced synergistic increases in hIK1
expression at days 3 and 5. These results are consistent
with the hypothesis that in human keratinocytes hIK1
may be both anti-proliferative and a positive regulator of
the differentiation process.
The effect of VitD on hIK1 levels was also assessed in cells
that had been previously exposed to elevated extracellular
calcium, simulating what might occur in intact skin when
VitD is therapeutically applied in part because of its pro-
differentiating properties. In this experiment hIK1 expres-
sion in basal calcium (0.06 mM) was 0.029% of GAPDH,
and after 48 hours in 2 mM calcium the value was
0.068%, similar to the result shown in figure 1. In cells
that were treated with 2 mM calcium for 24 hours fol-
lowed by addition of 1 µM VitD for another 24 hours
hIK1 expression was 0.165%, again comparable to results
shown in figure 1 for 24 hour calcium and VitD exposure.
GAPDH levels, which were used to normalize gene expres-
sion, varied little in response to calcium and/or VitD
(GAPDH Ct difference between untreated and treated
cells of 0.2 ± 0.2, N = 9 determinations), further substan-
tiating the robustness of the hIK1 upregulation results.
hIK1 mRNA expression in human skin biopsies
To directly assess the significance of the cell culture results
to intact skin, hIK1 mRNA was assayed in human skin
biopsies. To assess the variability of baseline hIK1 expres-
sion among skin samples, sets of three skin punch biop-
sies from each of three donors were placed in RNALater at
the donation site. hIK1 mRNA expression in these biop-
sies ranged from 0.10 to 0.21% of GAPDH expression,
with the values being quite consistent among biopsies
from a given donor as well as between donors (figure 2A).
Skin hIK1 expression values were somewhat higher than
those observed in cultured keratinocytes growing under
basal conditions (0.02% of GAPDH, 0.06 mM calcium no
added VitD). However, keratinocytes treated with VitD
alone or calcium and VitD expressed hIK1 at levels
comparable to those in skin. mRNA levels for involucrin
(INV) and transglutaminase-1 (TG-1), two contributors to
and markers of keratinocyte differentiation, also showed
little inter or intradonor variability. Expression levels for
INV (9.4 ± 1.6% of GAPDH, N = 9) and TG-1 (2.7 ± 0.4%,
N = 9) in the biopsies were higher than levels observed in
untreated cultured keratinocytes (INV 4.9 ± 0.7%, TG-1
0.74 ± 0.19%). However, treatment of cultured keratinoc-
ytes with calcium, VitD or both agents elevated levels of
INV (3.1-fold) and TG-1 (2.5-fold) into the ranges
observed for skin biopsies.
To determine the dynamics of hIK1 expression, hIK1
expression levels were measured as a function of time after
biopsy collection and subsequent growth in explant cul-
hIK1 mRNA expression is upregulated in human epidermal  keratinocytes under culture conditions which are anti-prolif- erative/pro-differentiating Figure 1
hIK1 mRNA expression is upregulated in human epi-
dermal keratinocytes under culture conditions which 
are anti-proliferative/pro-differentiating. Keratinocytes 
were grown in either proliferative (0.06 mM calcium), or 
anti-proliferative, pro-differentiating culture conditions (2 
mM calcium, 1 µM VitD, or both) for 1, 3, and 5 days. Total 
mRNA was harvested and processed for real-time PCR anal-
ysis. hIK1 mRNA levels are expressed as % of GAPDH 
mRNA, with data values at the top of each respective col-
umn. Each column represents the mean ± SEM for 2 to 6 cul-
tures treated as indicated. The far right data column is 
broken to allow scaling of the y-axis appropriate to the lower 
expression values. * indicates significant difference from 0.06 
mM calcium treatment at the indicated number of days.BMC Dermatology 2004, 4 http://www.biomedcentral.com/1471-5945/4/7
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Consistent hIK1 mRNA levels among biopsies from individuals and donor groups are maintained in explant culture Figure 2
Consistent hIK1 mRNA levels among biopsies from individuals and donor groups are maintained in explant 
culture. Real-time PCR analysis of mRNA expression levels (normalized to GAPDH) in human skin biopsies from healthy 
donors. (a) data points are hIK1 mRNA levels from three biopsies from each of three donors with mRNA harvesting per-
formed at time of biopsy collection. There were no statistically significance differences in hIK1 expression among the three 
donors. (b) effects of culture time on gene expression in explant biopsies assessed by measuring mRNA levels from biopsies 
preserved in RNALater at time of collection, and assessing fold changes from these levels in sibling biopsies shipped overnight 
in culture medium (1 day post collect), or shipped and kept in culture for 1 and 2 additional days (2 and 4 days post collect). 
Expression of involucrin (INV) and transglutaminase (TG-1) are shown for comparison with hIK1. Each data point is mean ± 
SEM for 3 biopsies. For any given gene there were no statistically significant differences in expression when comparing data 
from days one, two, and four.
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ture (figure 2B). Medium always contained 1.4 mM cal-
cium, a requirement for survival of explant skin cultures
[19]. At 2 days post collection (1 day shipping, 1 day in
culture) hIK1 expression had decreased to 40% of its ini-
tial value, but with an additional 2 days in culture expres-
sion had recovered to 60% of its initial value. TG-1
expression showed a similar decrease followed by an
increase with culture time, while INV increased insignifi-
cantly. Skin biopsies contain dermal fibroblasts that may
express hIK1. Although we trimmed much of the dermal
tissue from the biopsies used for this study, we cannot
completely discount some contribution of dermal fibrob-
lasts to the hIK1 expression results.
We examined the effect of VitD exposure over time on
skin explant hIK1 expression. In response to 1 µM VitD in
the culture medium hIK1 expression increased slightly to
approximately 1.5-fold of the untreated condition, and
remained elevated for the duration of the experiment (fig-
ure 3). INV and TG-1 expression remained relatively
unchanged at day one, followed by approximately 2-fold
increases at days three and five. Thus the ability of VitD to
enhance hIK1 mRNA expression in explant biopsies was
less than for cultured keratinocytes.
Effect of the hIK1 activator 1-EBIO on keratinocyte 
proliferation
The increase in hIK1 expression under anti-proliferative/
pro-differentiating growth conditions (calcium, VitD) was
surprising in that increased IK channel expression has typ-
ically been correlated with proliferative stimuli and
growth [1,2]. In addition, contact induced proliferative
inhibition in the HaCaT keratinocyte line correlated with
decreased hIK1 expression [9], and pharmacological
downregulation of hIK1 correlated with mitogenic inhibi-
tion [10]. However, differentiation marker expression did
VitD modestly upregulates mRNA for hIK1 (and INV, TG-1) in explant cultured skin biopsies Figure 3
VitD modestly upregulates mRNA for hIK1 (and INV, TG-1) in explant cultured skin biopsies. Real-time PCR 
analysis of mRNA expression levels (normalized to GAPDH) in human skin biopsies from healthy donors. Each column repre-
sents the mean ± SEM fold change in mRNA levels for three treated biopsies relative to three untreated, time-matched con-
trols. Changes in gene expression did not reach statistical significance.
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not increase, and it must be noted that proliferative inhi-
bition is not necessarily coupled to enhanced cell differen-
tiation. Our results correlating increased hIK1 expression
with keratinocyte differentiation are, however, consistent
with the general physiological model for this channel's
function, namely to enhance calcium influx. Thus, in
keratinocytes where calcium influx is a differentiation sig-
nal, hIK1 would be predicted to have anti-proliferative
and/or pro-differentiating functions.
To more directly test this hypothesis that hIK1 activation
would be inhibitory towards keratinocyte proliferation,
we looked at the effect of the hIK1 activator 1-EBIO on tri-
tiated thymidine incorporation, a measure of mitogenic
activity. Indeed, 1-EBIO inhibited mitogenesis with an
apparent IC50 slightly greater than 100 µM (figure 4), close
to the EC50 for 1-EBIO activation of the cloned hIK1 chan-
nel (74–84 µM, [20,21]). This effect was not due to 1-
EBIO induced cytotoxicity, as an LDH release based assay
showed no cytotoxicity up to 300 µM 1-EBIO (data not
shown). Surprisingly, however, mitogenic inhibition due
to 1-EBIO could not be reversed by any of a panel of hIK1
blockers, including ChTX (0.2 µM), clotrimazole (0.3
µM), and TRAM-34 (0.1 and 1 µM) [1,2,22]. The blockers
themselves did not inhibit mitogenesis except for a mod-
est effect of TRAM-34 (<30% inhibition) at the relatively
high concentration of 1 µM (400–500 times the IC50 for
IK block). The inability of these blockers to reverse
mitogenic inhibition by 1-EBIO called into question
whether hIK1 was indeed the target of 1-EBIO's anti-pro-
liferative action. Thus, these results required a functional
examination of hIK1 activity in primary keratinocytes.
Electrophysiological evaluation of hIK1 functional 
expression
To directly correlate expression and pharmacological data
with hIK1 channel function, we attempted to record hIK1
currents in keratinocytes. Whole cell patch clamp record-
ings were performed on a total of 41 keratinocytes. Only
recordings with seal resistances greater than 5 GΩ were
deemed acceptable for data acquisition. The number of
cells recorded for each treatment condition, and the
ranges of cell capacitances were as follows: 4 untreated,
12–19 pF; 4 at 2 mM calcium for 3 days, 18–35 pF; 14 at
1 µM VitD for 3 days, 14–40 pF; 11 at 1 µM VitD for 5
days, 27–58 pF; 5 at 1 µM VitD and 2 mM calcium for 3
days, 34–62 pF; 3 at 1 µM VitD and 2 mM calcium for 5
days 45–61 pF. The increase in cell capacitances (i.e., cell
area) in response to the differentiating agents calcium and
VitD is consistent with the increase in cell size observed
when cells withdraw from the cell cycle and differentiate.
Intracellular calcium in cells was increased via either the
patch pipette solution (10 µM free calcium) or by external
application of 10 µM A23187 for 1–2 minutes, but hIK1
currents, as evidenced by increased outward currents at 0
mV, were not observed under either condition (figure 5).
In 17 cells challenged with A23187, current amplitudes at
-70 and 0 mV were -42.3 ± 32.2 and -3.2 ± 5.6 pA respec-
tively before challenge, and -48.3 ± 29.2 and -4.4 ± 5.7 pA
after. An additional 21 cells exposed to 10 µM free cal-
cium via the patch pipette had current amplitudes of -54.1
± 45.2 pA and -1.5 ± 6.6 pA at -70 and 0 mV respectively,
again showing no significant calcium induced current
increase at 0 mV as would be expected for IK activation.
Three of the cells in the 5 day VitD group were also simul-
taneously exposed to the IK agonist 1-EBIO (100 µM) and
10 µM internal free calcium, but again no hIK1 currents
were evoked (current amplitude at 0 mV of -2.0 ± 4.2 pA).
Inside-out patches also were made from 3 additional cells
treated with VitD and calcium for 5 days, but no hIK1
channel activity was observed in these patches. We found
no evidence of voltage-gated currents in keratinocytes at
any test potentials investigated from -40 to 80 mV (data
not shown).
To assure that the recording conditions were satisfactory
for detecting hIK1 activity, we used the same solutions
and reagents to evoke mouse IK1 (mIK1) currents in ras-
transformed NIH3T3 cells (figure 5). Currents due to
mIK1, a homolog of hIK1 [23], were detected in all four
cells tested, with current amplitudes ranging from 0.78 nA
to 1.68 nA (figure 5). These experiments were performed
on the same day that identical recordings failed to detect
hIK1 in keratinocytes treated for 3 days with calcium and
VitD. The fact that all ras-transformed NIH3T3 cells tested
responded with large magnitude mIK1 currents is consist-
ent with previous reports from several groups, including
our own, concerning these cells [24,25].
mRNA levels for mIK1 and hIK1 were measured from cell
cultures made in parallel to those used for electrophysiol-
ogy. hIK1 levels in keratinocytes treated for 5 days with
calcium and VitD were approximately half of those for
mIK1 in ras-transformed NIH3T3 cells. This level of hIK1
expression was entirely consistent with the initial expres-
sion studies shown in figure 1. By comparison, channel
mRNA levels in wild type NIH3T3 and untreated keratino-
cytes were considerably lower. It is important to note,
however, that despite the 19-fold difference in mIK1
mRNA levels between wild type (0.41%) and ras-trans-
formed (7.97%) NIH3T3 cells, wild type cells still display
readily observable whole cell mIK1 currents at approxi-
mately 10% of the amplitude of ras-transformed cells
[24,25]. Further, the mIK1 mRNA level in wild type 3T3
cells is exceeded by hIK1 mRNA levels in keratinocytes
from the following treatment groups: VitD for 5 days;
VitD and calcium for 3 days; VitD and calcium for 5 days.
Therefore, although IK currents can be observed in 3T3
cells expressing mIK1 mRNA at approximately 0.4% of
GAPDH, no IK currents were observed in any of the 19BMC Dermatology 2004, 4 http://www.biomedcentral.com/1471-5945/4/7
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Inhibition of keratinocyte mitogenesis by the hIK1 agonist 1-EBIO is not reversed by hIK1 blockers charybdotoxin (ChTX),  clotrimazole (CLT) and TRAM-34 (TRAM) Figure 4
Inhibition of keratinocyte mitogenesis by the hIK1 agonist 1-EBIO is not reversed by hIK1 blockers charyb-
dotoxin (ChTX), clotrimazole (CLT) and TRAM-34 (TRAM). Keratinocyte mitogenesis was assessed by measuring tri-
tiated-thymidine incorporation over a 24 hour period. (A) single experiment, representative of four total, showing dose-
dependence of 1-EBIO inhibition of mitogenic activity. Mitogenic inhibition was significant (*) at the concentrations of 1-EBIO 
tested (ANOVA, 95% confidence interval). (B) Cumulative data showing failure of hIK1 blockers ChTX, clotrimazole, and 
TRAM-34 to reverse the inhibitory effect of 100 µM 1-EBIO on keratinocyte mitogenesis. Percent difference in thymidine 
incorporation versus untreated control cells plotted with each column representing mean ± SEM of 3–4 experiments. Num-
bers next to drugs indicate µM concentrations. 100 µM 1-EBIO, with or without hIK1 blockers present, caused significant 
reductions in thymidine incorporation relative to untreated control cells (indicated by asterisks). That is, blockers did not 
reverse inhibition due to 1-EBIO which would be expected if 1-EBIO was acting via agonism of hIK1. TRAM-34 itself caused 
significant proliferative inhibition but only at 1 µM.
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keratinocytes from cultures which express hIK1 mRNA at
0.7 to 4.4% of GAPDH.
Why are no functional hIK1 channels observed despite the 
fact that hIK1 mRNA is abundant and appears to be 
physiologically regulated?
Our results showing 1-EBIO inhibits keratinocyte prolifer-
ation suggest an involvement of hIK1 in this process, but
the hIK1 blocker ChTX failed to reverse this inhibition. 1-
EBIO has also been shown to modulate cell growth in the
HaCaT keratinocyte cell line, but 1-EBIO and other
benzimidazolones also affect chloride (and other)
conductances [26,27]. which are known to be present in
HaCaT [9,28]. Although the presence of chloride channels
in primary keratinocytes has not been addressed, it is pos-
sible that 1-EBIO affects proliferation in these cells and
HaCaT through channels other than hIK1, or through
some target yet to be determined. In addition, the electro-
physiological effects of 1-EBIO and indeed the presence of
hIK1 currents in HaCaT cells have not been subjected to
direct voltage clamp analysis [9,10]., therefore, a critical
electrophysiological comparison of these cells with pri-
Both NIH3T3 cells and calcium/VitD-treated keratinocytes have abundant IK1 mRNA but only NIH3T3 display IK1 currents Figure 5
Both NIH3T3 cells and calcium/VitD-treated keratinocytes have abundant IK1 mRNA but only NIH3T3 dis-
play IK1 currents. Top panels show whole cell patch clamp recordings from a keratinocyte (treated 5 days with 2 mM cal-
cium and 1 µM VitD) and ras-transformed NIH3T3 fibroblast. Each panel comprises records taken prior to and then during 1–
2 minute application of 10 µM A23187, a calcium ionophore which allows IK channel activity to be observed during voltage 
steps to 0 mV (voltage protocol shown beneath current records). mIK1 current is readily observed in ras-transformed NIH3T3 
cells in response to A23187, while hIK1 activity is absent from keratinocytes. Bottom panel shows real-time PCR analysis of IK 
mRNA levels from sibling cultures to those used for the patch clamp recordings (mIK1 for NIH3T3, hIK1 for keratinocytes). 
Each column represents mean ± SEM of two cultures. For comparison filled columns show mRNA levels for wild type (wt, 
non-transformed) NIH3T3 cells and untreated keratinocytes (0.06 mM calcium, no VitD).
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mary keratinocytes is not yet possible. Thus, it appears
that although hIK1 is expressed at the mRNA level in pri-
mary human keratinocytes as well as skin, functional
channels are not formed, and thus cell growth studies uti-
lizing hIK1 pharmacophores must be interpreted with
caution.
At present we have no mechanistic explanation for why
primary keratinocytes express hIK1 mRNA but lack any
apparent functional channels. One purely technical possi-
bility is that channels are produced but require cellular
conditions for activity that we could not reproduce during
the patch clamp experiments. However, IK channels are
quite functionally robust and all reported recording con-
ditions are straightforward and virtually identical, even in
cells as diverse as fibroblasts, T-cells, microglia, and
smooth muscle. A more interesting possibility is that hIK1
channels are produced in keratinocytes but they localize
to organellar membranes and not the plasma membrane.
This hypothetical intracellular hIK1 would not be
detected with conventional patch clamp techniques, and
it could be both sensitive to lipophilic compounds like 1-
EBIO while being protected from peptide toxins (e.g.,
ChTX). Despite this intriguing possibility a physiological
function for intracellularly localized IK channels is also
uncertain. Another possibility is that our TaqMan based
PCR was detecting a truncated [29] or splice variant hIK1
[30] which is electrophysiologically non-functional. To
address this possibility, the hIK1 mRNA upregulation
experiment shown in figure 1 was repeated, using end-
point PCR for the full-length hIK1 sequence instead of the
real-time method (which relies on detection of less than
100 bp out of the coding sequence). Figure 6 shows that
exposure to calcium or VitD for 5 days significantly
increases levels of full-length hIK1 mRNA. Further, com-
mercial sequencing (SeqWright Inc., Houston, TX) of the
PCR products showed the base content to be >90% iden-
tical to the reported hIK1 sequence, the non-matching
End-point PCR for the full-length protein coding sequence of hIK1 confirms real-time PCR results Figure 6
End-point PCR for the full-length protein coding sequence of hIK1 confirms real-time PCR results. Conventional 
end-point RT-PCR amplifying the coding sequence (1281 bp of 1284) of hIK1 was performed on keratinocytes grown for five 
days in either proliferative (0.06 mM calcium) or anti-proliferative, pro-differentiating (2 mM calcium, 1 µM VitD) culture con-
ditions. GAPDH, 615 bp of the complete coding sequence, is shown as a loading control. Full-length hIK1 message is upregu-
lated by VitD and more so by combining VitD with calcium, exactly as for the real-time PCR results (see figure 1).
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10% being due to sequencing ambiguities and incomplete
sequencing of the 3' and 5' ends. Most importantly,
sequencing showed no evidence for alternative first exons
as has been reported for the closely related SK3 channel to
encode non-functional, dominant negative variants
[30,31]. Finally, similar to our results with hIK1, calcium-
regulated expression of mRNA for certain P2Y purinergic
receptor subtypes in human keratinocytes has been
reported coincident with a lack of functional receptors
[32].
Conclusions
The critical role for calcium influx in keratinocyte prolifer-
ation and differentiation strongly indicates an electro-
physiological component to these processes, and hIK1 has
been modeled to serve an essential role in controlling cal-
cium mobilization in other non-neuronal, non-muscle
cell types. However, our results suggest that the functional
electrophysiology of primary human keratinocytes, and
possibly intact human skin, does not include hIK1. Fur-
ther, the lack of functional hIK1 channels suggests caution
must be used when interpreting results with IK1 pharma-
cophores in human epidermal keratinocyte cells and skin.
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